opulation-based cohort studies have identified many long-term risk factors for incident ischemic stroke that are both modifiable, such as high blood pressure, elevated serum cholesterol, and smoking, and nonmodifiable, such as male sex, nonwhite race, family history, and greater age. [1] [2] [3] Short-term risk factors-or triggers-of acute ischemic stroke include hypertensive crisis, 4 alcohol abuse, 5 and may also include acute infection. 5 Herein, we explore the relationship between hospitalization with infection and short-term stroke risk. Identifying and understanding stroke triggers offer potential strategies for stroke prevention during periods of vulnerability.
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Several case-control studies have reported an association between various measures of infection and ischemic stroke. [6] [7] [8] [9] [10] [11] [12] Two studies used a case-crossover design to identify an association between hospitalization with infection and short-term risk of ischemic stroke. 13, 14 Additionally, these 2 studies suggested that stroke risk after acute infection is greater in those with fewer vascular risk factors. 13 , 14 The authors hypothesized that acute triggers, such as infection, were less relevant in people with more vascular risk factors because they are already at elevated stroke risk.
Although recognition of infection as a trigger of ischemic stroke is growing, previous studies were often small, lacked prospective data, and failed to properly account for potential confounding factors. Furthermore, previous studies have considered effect modification by individual vascular risk factors but have not yet examined how the infection-stroke triggering association varies by overall CVD risk level.
We used the data collected in the long-running, prospective cohort Atherosclerosis Risk in Communities (ARIC) study to study the association further. On the basis of the previous literature, we hypothesized that there is an association between hospitalization with infection and acute ischemic stroke risk and that infection is a stronger stroke trigger among patients with low background CVD risk.
Methods

Study Population
The ARIC study is a prospective population-based cohort study comprising 15 792 adults aged 45 to 64 years at recruitment in [1987] [1988] [1989] . 15 Subsequent exams took place during 1990 to 1992 (visit 2), 1993 to 1995 (visit 3), 1996 to 1998 (visit 4), and 2011 to 2013 (visit 5). Cohort participants were selected from 4 US communities: Forsyth County, North Carolina; Jackson, Mississippi; suburbs of Minneapolis, Minnesota; and Washington County, Maryland. A detailed discussion of ARIC study design and objectives is provided elsewhere.
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Study Design
A case-crossover study design was used in which all ARIC participants who had an ischemic stroke during follow-up (n=1062) served as their own control. The case-crossover design affords the ability to isolate exposures that vary over time within person and better control for potential confounding that might occur between people. The occurrence of hospitalization with infection at intervals of 14, 30, 42, and 90 days before the stroke date were compared with 2 preceding control periods (1 year and 2 years before stroke). A washout period between the stroke admission date and preceding hospitalization with infection discharge date was used to exclude infections that may have been diagnosed secondarily at a stroke hospitalization. Cases whose control periods occurred before ARIC study enrollment were excluded (n=54) leaving a study sample of n=1008. The study design is summarized in Figure. 
Stroke Ascertainment
Incident ischemic strokes were ascertained from hospitalizations reported by annual contact with participants, cardiovascular disease discharge lists provided by local hospitals, and death certificates. Incident ischemic strokes were identified and classified as thrombotic or cardioembolic by a computer algorithm and physician review based on signs, symptoms, neuroimaging (computerized tomography/ magnetic resonance imaging), and other diagnostic reports, according to criteria adapted from the National Survey of Stroke. Details on quality assurance for ascertainment and classification of ischemic stroke events are published elsewhere. 3 All definite and probable incident ischemic strokes between study enrollment and end of year 2011 were included in the analysis.
Main Independent Variable: Hospitalization With Infection
The exposure of interest was hospitalization with infection up to 90 days before ischemic stroke for the case period and equivalent 90-day control periods exactly 1 year and 2 years before the ischemic stroke. The admission date for hospitalization with stroke was considered the stroke date, whereas the discharge date for hospitalization with infection was considered the infection date. Infection was assessed using abstracted hospital record discharge Codes in any position were counted. A washout period was used to exclude infections that may have been diagnosed secondarily at a stroke hospitalization. Washout periods of both 2 and 4 days between stroke admission date and preceding hospitalization with infection discharge date were used and compared.
Measurement of Other Covariates
Background CVD risk was measured using the American College of Cardiology/American Heart Association 10-year CVD risk score. 16 The CVD risk score uses sex, age, race, total cholesterol, blood pressure, diabetes mellitus status, and smoking status to estimate 10-year CVD risk based on pooled cohort data. Data on risk factors were obtained at baseline (visit 1) and again during follow-up visits. We compared CVD risk score ascertained at baseline with that assessed at the participant's study visit before the first control period to examine any differences in the magnitude of the associations of interest.
Statistical Analysis
Potential confounders that are stable within an individual are controlled in the case-crossover study design by having cases serve as their own controls, a type of individual matching. Confounding by overall health status related to age is possible because deteriorating health could be a common cause of both infection and stroke. As participants age and their health status decreases, their stroke risk and hospitalization with infection risk may increase, suggesting potential positive confounding by health status.
To reduce potential confounding, only time periods proximal to stroke (1 year and 2 years before) were included. We further controlled for the total number of hospitalizations in the 9 months preceding the start of each of the 3 exposure periods (case period and 2 control periods) to account for potential decline in overall health status.
The prevalence of hospitalization with infection 14, 30, 42, and 90 days before ischemic stroke was compared with the corresponding time periods exactly 1 year and 2 years before the stroke. Conditional logistic regression was used to estimate odds ratios (OR) of stroke and 95% confidence intervals (CIs) for each time period (14, 30, 42 , and 90 days). Interactions between hospitalized infection and CVD 10-year risk score, modeled continuously, were tested by adding an interaction term to the conditional logistic regression models. ORs associated with hospitalized infection were also estimated after dichotomizing CVD risk score at the median (10.00% for visit 1 and 15.38% for most recent visit) for ease of interpretation. Finally, models stratified by ischemic stroke subtype (thrombotic and cardioembolic) were considered to evaluate if the infection-stroke triggering effect differed by ischemic stroke subtype. Ischemic stroke subtype
Figure.
Case-crossover study design used to study stroke in relation to triggering by hospitalized infection, ARIC. Presence of hospitalized infection was assessed for each of the 12 time periods, and case period was compared with control periods. ARIC indicates Atherosclerosis Risk in Communities.
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definitions previously published in the ARIC study literature were used. 3 For all analyses, both crude models and models adjusted for the number of hospitalizations were evaluated and presented.
Results
Of the 15 792 ARIC participants, 4964 (31.4%) had at least 1 hospitalization with infection during follow-up, and 1062 (6.7%) had an ischemic stroke. Of the 1062 strokes identified during the follow-up period, 54 were excluded because their control periods occurred before ARIC study enrollment, leaving a total of 1008 strokes for analysis. Baseline (ARIC visit 1) characteristics are provided in Table 1 for both stroke participants and nonstroke participants (for comparison). The majority of the stroke participants were white (60%), they were equally split between males and females, and had an average age of 56 years at baseline. Of the 1008 stroke participants, 37 had a hospitalization with infection during the preceding 90 days. Models constructed using a 4-day washout period produced results similar to the models constructed using a 2-day washout, and thus, only models using a 2-day washout period are presented. As shown in Table 2 , hospitalized infection was more common in all case periods compared with equivalent control periods, but the ORs decrease with elapsed time: 14-day OR, 7.7 (95% CI, 2.1-27.3); 30-day OR, 5.7 (95% CI, 2.3-14.3); 42-day OR, 4.5 (95% CI, 2.0-10.2), and 90-day OR, 3.6 (95% CI, 2.1-6.5). Controlling for the number of hospitalizations slightly attenuated the association between hospitalization with infection and stroke.
In all interaction models, the infection-stroke association was stronger in those with low background CVD risk compared with those with high background CVD risk (Table 3) . These interactions were significant for CVD risk measured at visit 1 for the 30-day (OR high CVD risk: 2.5 versus OR low CVD risk: 28.0) and 42-day (OR high CVD risk: 2.0 versus OR low CVD risk: 14.0) periods, and borderline significant for CVD risk measured at the most recent visit for the 30-day (OR high CVD risk: 3.5 versus OR low CVD risk: 26.0) period.
Results from the analysis stratified by ischemic stroke subtype are presented in Table 4 . The infection-stroke association was stronger among thrombotic strokes for the 14- 
Discussion
This case-crossover study within a population-based cohort demonstrated that ischemic stroke risk is higher after hospitalization with infection. Patients with infection had higher odds of stroke up to 90 days after the hospitalization with infection compared with equivalent control periods 1 year and 2 years before stroke. This supports our hypothesis that hospitalized infection is associated with higher ischemic stroke risk. The association between hospitalization with infection and stroke was graded, such that stroke risk was highest in the exposure periods most proximal to the stroke event and decreased as the time window before stroke increased. These results corroborate previous work that found that infection may function as a stroke trigger and that the stroke risk varies by time since infection. 13 We found some evidence that stroke risk after hospitalization with infection seems to be more prominent in those with low background CVD risk. This pattern of interaction is consistent with results reported by Elkind et al, 13 but corroboration with larger studies is needed. Although the infectionstroke association may be stronger for cardioembolic strokes, it is difficult to determine if infection is a stronger trigger for a particular stroke subtype given the imprecise estimates and wide confidence intervals because of small cell sizes.
Previous investigators have suggested possible mechanisms by which infection can trigger CVD events. Corrales-Medina et al 17 posited mechanisms by which infection may trigger coronary events, including via inflammation, prothrombosis, increased biomechanical stress on coronary arteries, variations in the coronary arterial tone, disturbed hemodynamic homoeostasis, and altered myocardial metabolic balance. Considering stroke, specifically, Elkind et al 13 suggest that infection may trigger stroke events through hypercoagulability, platelet activation, and impaired endothelial function. They further hypothesize that infection may contribute to dehydration and immobility which increase stroke risk. 13 Additional research on the mechanisms linking infection and stroke including considering infection and stroke triggering by infection and stroke subtype is warranted.
Our study has several strengths, including a large sample size from a community cohort, a rigorous methodology to adjudicate 
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ischemic strokes, and a crossover design to control for potential confounding. It also has limitations. Like all case-crossover studies, our study may experience survival bias because we did not consider infections in participants who did not have a stroke. Confounding by age is possible because as participants age, their risk of both stroke and hospitalization with infection increase. To reduce potential confounding, only time periods proximal to stroke (1 year and 2 years before stroke) were examined, and the total number of hospitalizations was included in the adjusted models. Other confounders such as medication use that may vary between the exposure and control periods were not measured. Relatively few infections before stroke yielded OR estimates that were imprecise, with wide CIs. Because we used the hospital admission as the stroke date, stroke dates for patients who do not seek immediate medical attention may be inaccurate, but we think that this is rare because most patients immediately seek care. We certainly are underascertaining infections, especially minor ones, by including only hospitalizations with infections. This would most likely lead to nondifferential misclassification of the exposure that would typically bias ORs toward the null. Our study has several implications. Identification of hospitalization with infection as a stroke trigger may prompt more aggressive treatment with standard preventive strategies, including antiplatelet agents and statins, during and immediately after hospitalization with infection to reduce the increased risk of acute stroke. This time period immediately after infection is referred to as a treatable moment. 13 Although antibiotics have not been shown to prevent vascular events, [18] [19] [20] other infection control efforts, including evidence-based vaccination, may be considered because of their ability to not only reduce infection but also stroke. 21 Furthermore, considering past infections may help clinicians identify causes of so-called cryptogenic strokes.
Conclusions
Patients with ischemic stroke have higher odds of a hospitalization with infection up to 90 days before their stroke compared with equivalent control periods 1 year and 2 years before stroke. Stroke risk after hospitalization with infection seems to be higher in those with low background CVD risk. There may be a role for primary prevention with antiplatelet therapy in the immediate aftermath of an infection, although clinical trials and cost-benefit analysis should be considered. 
